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Tuesday, February 28, 2012 437aagent colchicine that is known to increase free tubulin, mitochondrial potential,
as measured by tetramethylrhodamine methyester (TMRM) uptake, decreased.
Inhibition of PKA activity with H89 increased mitochondrial potential and, fur-
thermore, reversed mitochondrial depolarization induced by colchicine. To fur-
ther explore a role VDAC-tubulin interaction in cell proliferation and survival,
we studied the effect of erastin, the selective anti-tumour agent involved in the
RAS-RAF-MEK signalling pathway, on VDAC blockage by tubulin. We found
that erastin reverses tubulin blockage of VDAC isolated from HepG2 cells, pro-
moting the unblocked state of the channel. Our findings suggest a novel func-
tional link between serine/threonine kinase signalling pathways, mitochondrial
respiration, and highly dynamic microtubule network which is characteristic of
carcinogenesis and cell proliferation.
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VDAC proteins represent a main component of the outer mitochondrial mem-
brane (OMM). The VDAC family is composed of 3 isoforms with more than 70
percent similarity. Although their primary role was known to be in ion and me-
tabolite transport between mitochnodria and cytosol, it has been discovered that
VDACs are involved in apoptotic pathways. We have recently found that spe-
cifically the VDAC2 isoform is needed for tBid-induced cytochrome c release,
due to its role in supporting Bak insertion to the OMM (Roy et al.2009. EMBO
Rep.10:1341-7). Sequence analysis of the mammalian VDAC isoforms shows
a unique N terminal end in VDAC2, which is likely to be exposed to the cyto-
plasm. To test the functional significance of this N terminus, the first 12 amino
acids were removed from VDAC2 or were added to VDAC1. VDAC2-/- MEF
cells that are resistant to tBid, were rescued with these constructs and cyto-
chrome c release was monitored in permeabilized cells by single cell imaging
and immunoblotting. These studies revealed that cytochrome c release upon
tBid application is effectively supported by both full length VDAC2 and the
VDAC2 N-terminal deletion mutant. Furthermore, VDAC1 extended by the
N terminus of VDAC2 failed to restore cytochrome c release in VDAC2-/-
MEFs. Thus the N terminus of VDAC2 seems to be dispensible for tBid-
induced OMM permeabilization. Currently, we are designing different muta-
tions which target some addititional unique sequences in VDAC2 to find the
specific domain that is essential for tBid induced cytochrome c release.
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The mitochondrial Ca2þ uptake has been recognized as a central player in cel-
lular pathophysiology for decades. Pathways of Ca2þ transport across the inner
mitochondrial membrane (IMM) were investigated indirectly with biochemical
techniques and most recently by applying the patch clamp technique to mito-
plasts isolated from mammalian systems. Patch-clamp recording of the IMM
have proved to provide an unambiguous picture of mitochondrial Ca2þ uptake
under strictly controlled conditions.
In this study, we evaluated and compared the biophysical properties of mito-
chondrial Ca2þ uptake in different mouse tissues. Freshly isolated mitoplasts
from mouse heart, skeletal muscle, liver, kidney, spleen and brown adipose tis-
sue were patch clamped in the whole-mitoplast configuration. Voltage step and
ramp protocols covering the whole range of physiological potentials were ap-
plied to elicit the inwardly rectifying Ca2þcurrent sensitive to RuR known as
MCU. The distribution of MCU current densities between tissues was as fol-
lows: spleen > brown adipose tissuez skeletal muscle > kidney > liver >>
heart. Interestingly, MCU current density in heart was about 10 times smaller
than in skeletal muscle. Our results support the view of a differential tissue
activity of MCU, which can be explained by either a different distribution of
MCU channel and/or by a different expression of its regulatory subunits confer-
ing various modes of physiological regulation.
Further on, in order to investigate the putative direct contribution of Uncou-
pling Protein Isoform 2 and 3 (UCP2/3) to the uniporter, we investigated
MCU properties in wild type (WT) mouse tissues where these two proteins
have been found to have a major role and compared its properties in the corre-
spondent tissues of UCP2 and UCP3 KO mice. We found no significant differ-
ences in calcium currents of any of the WT tissues studied compared to their
UCP2/3 KO counterparts.2218-Plat
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Chronic alcoholism causes various forms of stress in the heart, and this is often
accompanied by mitochondrial dysfunction. A putative source of mitochondrial
dysfunction is SR-mitochondrial stress and the ensuing mitochondrial Ca2þ
overload. To test this possibility, first we isolated mitochondria from chronic
ethanol-fed (6 months) and paired control rats, and documented ethanol-
dependent sensitization to Ca2þ and ROS-induced permeabilization. To evalu-
ate the ultrastructural basis of the mitochondrial impairments, we performed
transmission electron microscopy (TEM) and electron tomography studies of
left ventricular muscle. The overall ultrastructure of the myocytes became
less organized in the ethanol-fed condition. Also, a considerable fraction of
the mitochondria lost the highly ordered structure of the cristae and showed
an increase in the cross-sectional area. However, the size of the SR-
mitochondrial associations and the gap-width at the interface was unchanged.
Evaluation of the SR-mitochondrial tethers by electron tomography indicates
that they occur in clusters and display heterogeneity in length, as previously re-
ported for ER-mitochondrial tethers in normal rat liver (Csordas et al, 2006, J
Cell Biol, 174:915). Overall tether length distribution appears to be unaltered
by alcohol ingestion. Analyses of effects of alcohol ingestion on tether
membrane-surface density and structural classes (linear, V, Y and more com-
plex shapes) is in progress, as is 3D analysis of SER and mitochondrial inner-
and outer-membrane topologies. (Supported by NIH grant 1RC2AA019416.)
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We report that, in non-apoptotic pro-lymphocyte cells, Bcl-xL induced an in-
crease of the mitochondrial localization of Bax up to the level found in apopto-
tic cells. Furthermore Bcl-xL stimulated both the active conformation of Bax
and increased the total amount of Bax inserted in the outer mitochondrial mem-
brane. In order to further investigate the molecular mechanisms involved in this
effect, different Bax and Bcl-xL mutants were co-expressed in yeast. We found
that wild-type Bcl-xL increased the mitochondrial localization of both wild-
type Bax and of an active mutant Bax-S184D, while mutant Bcl-xL-G138A
did not have this effect. Further, wild-type Bcl-xL protected Bax-S184D
against proteolytic degradation. Finally, we found that a C-terminally truncated
mutant of Bcl-xL, that lost its capacity to inhibit Bax-induced release of cyto-
chrome c, still increased the mitochondrial localization of wild-type Bax, thus
promoting the release of cytochrome c. These data suggest that Bcl-xL, by act-
ing as a modulator of mitochondrial Bax localization, may play an active role
along the pathway leading to Bax activation.
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Apoptosis - programmed cell death - is vital for multicellular organisms to dis-
pose of redundant, damaged or infected cells. This mechanism becomes dys-
functional in cancer where tumor cells survive drug-induced death signals.
Reversely, upregulated apoptosis can induce premature neuronal cell death
in amyloidogenic diseases such as Alzheimer’s disease (AD) or Amyotrophic
Lateral Sclerosis (ALS). Mitochondrion, the power plant of the cell, contains
an arsenal of proteins which regulate programmed cell death. There, the pro-
and anti-apoptotic Bcl-2 proteins meet at the mitochondrial membrane to
decide the fate of a cell. How the molecular activities of the anti-apoptotic
438a Tuesday, February 28, 2012Bcl-2 - the major regulating protein - and its interplay with the mitochondrial
membrane system are being transferred as physiological consequences at the
organelle (mitochondrion) and cellular level is still mysterious. Therefore,
we use a biophysical, solid state NMR based approach to develop a mitochon-
drion based test system, where we can study the physiological response of in-
tact mitochondria of various origin (cancer, healthy, ALS motor neurons) ex
vivo upon apoptotic stress ranging from novel cancer drugs to amyloidogenic
proteins such as A-beta protein or SOD1 protein, the main culprits in AD
and ALS, respectively.
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Reperfusion of a previously ischemic myocardium is a critical life-saving in-
tervention against tissue necrosis, but reperfusion itself also results in signif-
icant damage to myocardium. Many therapeutic strategies such as ischemic
and volatile anesthetic pre- and postconditioning have been suggested but
few have translated effectively to humans. Near infrared and far red light
(NIR) has been demonstrated to protect the myocardium against ischemia
and reperfusion (IR) injury. The beneficial effect of NIR is mediated in
part by an increase in nitric oxide (NO) bioavailability. Under hypoxic con-
ditions, heme-containing proteins such as myoglobin (Mb) and hemoglobin
(Hb) exhibit nitrite reductase activity which results in an increase in NO
bound to Mb and Hb. NIR treatment is thought to cause a photolysis of
MbNO and HbNO which results in an increase in active NO when applied
at the time of reperfusion. We hypothesize that NIR-enhanced NO during
reperfusion modulates mitochondrial bioenergetics by interaction with the
electron transport chain and thereby may induce cardioprotection. Isolated
mitochondria were incubated with substrate and ADP in an air tight chamber.
Oxygen consumption of mitochondria created a hypoxic environment,
simulating conditions of ischemic myocardium. Deoxymyoglobin and nitrite
were added to the reaction chamber during the hypoxic period and then reox-
ygenation was performed in the presence and absence of NIR (670 nm,
50 mW/cm2). A faster reoxygenation of the chamber, corresponding to an
inhibiton of mitochondrial respiration was observed when the reaction was
exposed to NIR during hypoxia and throughout reoxygenation. This mild in-
hibition of mitochondrial respiration by NIR may decrease reactive oxygen
species during reoxygenation and thereby lead to increased cell viability. In-
terestingly, in a diabetic mouse model (db/db) were ischemic or anesthetic
postconditioning fail to protect the myocardium against IR injury, NIR treat-
ment decreased infarct size.
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Mitochondrial potential (DJ) loss is a critical event during myocardial is-
chemia. Potentiometric dye TMRM accumulates inside well-polarized mito-
chondria and is used as an DJ indicator. However, during no-flow ischemia
(NF-ISCH) total TMRM fluorescence may remain unchanged despite DJ
loss. We sought to improve detection of DJ loss during NF-ISCH
using SFT. Langendorff-perfused rabbit hearts (n=8) were stained with
TMRM (400 nM). Motion was abolished by Blebbistatin (5 mM). TMRM
fluorescence was recorded confocally from left ventricular subepicardium
(0.5mm/pixel, 20x objective lens) in control, while perfusing mitochondrial
uncoupler FCCP (5 mM), and after 65515 min of NF-ISCH. In control
SFT revealed distinct peaks (MITO-PEAKs) at spatial frequency of
12.3750.06 mm along the
longitudinal axis of myocytes
(Figure), possibly related to
the sarcomere length. MITO-
PEAKs were greatly de-
pressed after FCCP (not
shown) and NF-ISCH (Fig-
ure). Normalized spectral
power under MITO-PEAKs
was significantly different
between control and FCCP
(p=0.019), and control and
NF-ISCH (p=0.016). In con-trast, total TMRM brightness failed to reveal significant difference (control
vs. FCCP, p = 0.077; control vs. NF-ISCH, p=0.678). Thus, analysis of
MITO-PEAKs in SFT spectrum provides a robust method for detecting
DJ loss in ischemic myocardium.Workshop: Measuring, Modeling, and Designing
Protein Recognition Specificity
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Design of protein interactions is a key challenge in molecular biology and
would open new routes for biomedical research and biotechnology. We devel-
oped a general computational method for designing proteins that bind a surface
patch of interest on a target macromolecule. Favorable interactions between
disembodied amino acid residues and the target surface are identified and
used to anchor de novo designed interfaces. The method was used to design
proteins that bind a conserved surface patch on the stem of the influenza
hemagglutinin (HA) from the 1918 H1N1 pandemic virus. After affinity matu-
ration, two of the designed proteins, HB36 and HB80, bind H1 (Spanish influ-
enza) and H5 (avian influenza) HAs with picomolar affinity. Further, HB80
inhibits the HA fusogenic conformational changes induced at low pH. The
crystal structure of HB36 in complex with 1918/H1 HA revealed that the
actual binding interface is nearly identical to that in the computational design
model. Affinity-increasing mutations isolated through experimental affinity
maturation helped shed light on crucial elements which are missing in compu-
tational design calculations, such as long-range electrostatics. These have been
incorporated in design calculations to improve the computational method’s
ability to generate de novo designed binders and inhibitors. Such designed
binding proteins may be useful as diagnostics, therapeutics, and molecular
probes.
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Over the last decade, therapeutic monoclonal antibodies represent one of the
major breakthroughs for the treatment of cancer and other diseases. To date,
most therapeutic antibodies have been obtained by the humanization of
rodent-derived antibodies, but in recent years, research in antibody engineer-
ing has given rise to a new wave of technologies that promise to transform
the field. Phage-displayed libraries of ‘‘synthetic antibodies’’ use entirely
man-made antigen-binding sites and thus circumvent the need for natural im-
mune repertoires. Using in vitro selections, highly functional antibodies with
fully human frameworks can be generated against virtually any antigen in
a matter of weeks. Access to the encoding DNA allows for rapid affinity mat-
uration, fine tuning of specificity and recasting into different molecular for-
mats. We have developed particularly simple synthetic antibodies that use
a single human framework and limited chemical diversity in restricted regions
of the antigen-binding site. These structural simplifications enhance the perfor-
mance of the libraries, which have yielded highly functional and stable anti-
bodies against numerous diverse antigens. These libraries are capable of
fulfilling all of the roles of natural antibodies, and furthermore, they extend
the use of antibody technologies to many challenging problems, such as the
recognition of conformational changes, post-translational modifications, struc-
tured nucleic acids and integral membrane proteins. Moreover, the recombi-
nant nature of synthetic antibodies makes them ideal reagents that can be
used as crystallization chaperones to aid the elucidation of structures for com-
plex antigens. Extending the synthetic concept even further, we have devel-
oped novel binding scaffolds that enable applications beyond the range of
antibodies, and these include the development of scaffolds that can be synthe-
sized completely using peptide chemistry and scaffolds that fold and function
inside cells.
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The ability to alter or inhibit protein interactions specifically would advance
basic and applied biomolecular science. Increasingly, protein interactions in
the cell are found to be mediated by conserved recognition domains. For this
reason, robust targeting of individual proteins will require solutions to the
